Coverage
-
February 04, 2022
A Delaware federal judge has ordered Belcher Pharmaceuticals to foot the bill for Pfizer unit Hospira in Belcher's patent infringement suit over epinephrine injector Abboject, finding that the accuser's antics during the litigation — and the "weak" suit it lodged — called for the company to cover Hospira's fees.
1 other articles on this case.
View all »